Brooks Laboratories Limited (NSE:BROOKS) — Stock Price
Brooks Laboratories Limited (NSE:BROOKS) is currently trading at Rs59.90 INR, down 0.18% today. Over the past 52 weeks, shares have ranged between Rs37.11 and Rs159.04. This page tracks Brooks Laboratories Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Brooks Laboratories Limited worth.
Brooks Laboratories Limited (BROOKS) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Brooks Laboratories Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Brooks Laboratories Limited Income Statement — Revenue, Profit & Earnings by Year
Brooks Laboratories Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | Rs825.57 Million | Rs794.86 Million | Rs624.80 Million | Rs911.85 Million | Rs770.68 Million |
| Cost of Revenue | Rs686.35 Million | Rs729.24 Million | Rs506.02 Million | Rs757.99 Million | Rs552.40 Million |
| Gross Profit | Rs139.22 Million | Rs225.13 Million | Rs126.02 Million | Rs-79.11 Million | Rs218.28 Million |
| Research & Development | — | — | — | — | — |
| SG&A | Rs129.60 Million | Rs43.71 Million | Rs100.88 Million | Rs88.40 Million | Rs65.54 Million |
| Total Operating Expenses | Rs105.84 Million | Rs51.18 Million | Rs460.48 Million | Rs361.05 Million | Rs284.28 Million |
| Operating Income | Rs33.37 Million | Rs11.99 Million | Rs-68.98 Million | Rs77.38 Million | Rs-108.43 Million |
| EBITDA | Rs58.22 Million | Rs41.73 Million | Rs-291.68 Million | Rs-134.50 Million | Rs12.52 Million |
| EBIT | Rs42.20 Million | Rs24.00 Million | Rs-361.95 Million | Rs-208.01 Million | Rs-58.91 Million |
| Interest Expense | Rs10.28 Million | Rs8.45 Million | Rs21.83 Million | Rs30.97 Million | Rs30.98 Million |
| Income Before Tax | Rs-97.92 Million | Rs-195.66 Million | Rs-383.78 Million | Rs-238.98 Million | Rs-89.93 Million |
| Income Tax Expense | Rs1.75 Million | Rs259.00K | Rs-73.24 Million | Rs-45.85 Million | Rs103.82 Million |
| Net Income | Rs-99.67 Million | Rs-195.92 Million | Rs-209.00 Million | Rs-193.13 Million | Rs-193.75 Million |
Brooks Laboratories Limited Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Brooks Laboratories Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | Rs1.24 Billion | Rs904.45 Million | Rs1.10 Billion | Rs1.96 Billion | Rs1.62 Billion |
| Total Current Assets | Rs338.77 Million | Rs310.48 Million | Rs275.06 Million | Rs611.82 Million | Rs478.01 Million |
| Cash & Equivalents | — | — | Rs232.00K | Rs26.05 Million | Rs8.84 Million |
| Short-term Investments | Rs23.45 Million | Rs23.33 Million | Rs13.55 Million | Rs12.05 Million | Rs12.57 Million |
| Net Receivables | Rs199.92 Million | Rs163.16 Million | Rs130.57 Million | Rs190.31 Million | Rs137.47 Million |
| Inventory | Rs92.05 Million | Rs96.11 Million | Rs113.03 Million | Rs275.22 Million | Rs236.03 Million |
| Property, Plant & Equipment | Rs139.72 Million | Rs136.00 Million | Rs148.09 Million | Rs1.24 Billion | Rs1.08 Billion |
| Goodwill | — | — | — | — | — |
| Total Liabilities | Rs255.90 Million | Rs248.60 Million | Rs356.44 Million | Rs615.91 Million | Rs829.29 Million |
| Total Current Liabilities | Rs228.44 Million | Rs230.48 Million | Rs330.21 Million | Rs488.78 Million | Rs637.14 Million |
| Long-term Debt | Rs1.30 Million | Rs0.00 | Rs0.00 | Rs92.91 Million | Rs144.40 Million |
| Net Debt | Rs63.35 Million | Rs55.16 Million | Rs64.89 Million | Rs226.53 Million | Rs305.01 Million |
| Total Stockholder Equity | Rs981.04 Million | Rs655.85 Million | Rs739.53 Million | Rs874.90 Million | Rs791.48 Million |
| Retained Earnings | Rs-486.52 Million | Rs-386.85 Million | Rs-191.01 Million | Rs-236.18 Million | Rs-138.49 Million |
Brooks Laboratories Limited Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Brooks Laboratories Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | Rs17.62 Million | Rs-96.81 Million | Rs-144.91 Million | Rs-374.41 Million | Rs44.59 Million |
| Capital Expenditures | Rs18.59 Million | Rs4.39 Million | Rs4.67 Million | Rs276.12 Million | Rs56.14 Million |
| Free Cash Flow | Rs-971.00K | Rs-101.20 Million | Rs-149.58 Million | Rs-650.53 Million | Rs-11.55 Million |
| Investing Cash Flow | Rs-460.41 Million | Rs1.82 Million | Rs4.95 Million | Rs-249.09 Million | Rs-51.30 Million |
| Financing Cash Flow | Rs441.96 Million | Rs96.01 Million | Rs114.14 Million | Rs640.71 Million | Rs11.59 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | Rs16.02 Million | Rs17.73 Million | Rs70.27 Million | Rs73.51 Million | Rs71.43 Million |
| Change in Cash | Rs5.55 Million | Rs1.02 Million | Rs-25.82 Million | Rs17.21 Million | Rs4.88 Million |
Brooks Laboratories Limited Earnings History — EPS Actual vs. Analyst Estimates
Track Brooks Laboratories Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 26, 2026 | — | — | — |
| Feb 11, 2026 | — | — | — |
| Nov 07, 2025 | — | — | — |
| Aug 12, 2025 | — | — | — |
| Jan 29, 2025 | — | — | — |
| Nov 07, 2024 | — | — | — |
| Aug 13, 2015 | 0.94 | 1.02 | -7.84% |
| Mar 31, 2015 | 1.09 | 1.22 | -11.02% |